{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:37:23Z","timestamp":1791859043235,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"15-16","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.lfs.2011.02.017","type":"journal-article","created":{"date-parts":[[2011,2,27]],"date-time":"2011-02-27T09:33:27Z","timestamp":1298799207000},"page":"730-736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":203,"title":["Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: Role of phenolic hydroxyl groups in the resorcinol moiety"],"prefix":"10.1016","volume":"88","author":[{"given":"Satoshi","family":"Yamaori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juri","family":"Ebisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimi","family":"Okushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2011.02.017_bb0005","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1600-6143.2005.00745.x","article-title":"Consequences of genetic polymorphisms for sirolimus requirements after renal transplant in patients on primary sirolimus therapy","volume":"5","author":"Anglicheau","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.lfs.2011.02.017_bb0010","doi-asserted-by":"crossref","first-page":"10388","DOI":"10.1016\/S0021-9258(18)81632-5","volume":"264","author":"Aoyama","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lfs.2011.02.017_bb0015","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1248\/cpb.16.822","article-title":"Forensic chemical study on marihuana. I. A detection method of the principal constituents by thin-layer and gas chromatographies","volume":"16","author":"Aramaki","year":"1968","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.lfs.2011.02.017_bb0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0041-008X(87)90338-3","article-title":"Fetal disposition of \u03949-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey","volume":"90","author":"Bailey","year":"1987","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.lfs.2011.02.017_bb0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/clpt.1980.139","article-title":"Metabolic and psychophysiologic studies of cannabidiol\u2013hexobarbital interaction","volume":"28","author":"Benowitz","year":"1980","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.lfs.2011.02.017_bb0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0026-895X(25)12946-5","article-title":"Purification and characterization of the major hepatic cannabinoid hydroxylase in the mouse: a possible member of the cytochrome P-450IIC subfamily","volume":"40","author":"Bornheim","year":"1991","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.lfs.2011.02.017_bb0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0090-9556(25)08572-1","article-title":"Human hepatic microsomal metabolism of \u03941-tetrahydrocannabinol","volume":"20","author":"Bornheim","year":"1992","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.lfs.2011.02.017_bb0040","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/0006-2952(78)90547-6","article-title":"The effect of cannabinoids (\u03949-THC and \u03948-THC) on hepatic microsomal metabolism of testosterone in vitro","volume":"27","author":"Chan","year":"1978","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.lfs.2011.02.017_bb0045","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0090-9556(24)15185-9","article-title":"Catalysis of the 4-hydroxylation of retinoic acids by CYP3A7 in human fetal hepatic tissues","volume":"28","author":"Chen","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.lfs.2011.02.017_bb0050","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.lfs.2005.09.011","article-title":"Chemical constituents of marijuana: the complex mixture of natural cannabinoids","volume":"78","author":"ElSohly","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.lfs.2011.02.017_bb0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1520\/JFS14636J","article-title":"Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980\u20131997","volume":"45","author":"ElSohly","year":"2000","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.lfs.2011.02.017_bb0060","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1016\/0006-2952(73)90184-6","article-title":"Interactions of several cannabinoids with the hepatic drug metabolizing system","volume":"22","author":"Fernandes","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.lfs.2011.02.017_bb0065","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1248\/cpb.38.1697","article-title":"In vivo and in vitro metabolism of cannabidiol monomethyl ether and cannabidiol dimethyl ether in the guinea pig: on the formation mechanism of cannabielsoin-type metabolite from cannabidiol","volume":"38","author":"Gohda","year":"1990","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.lfs.2011.02.017_bb0070","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0006-2952(94)90543-6","article-title":"Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily","volume":"47","author":"Gorski","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.lfs.2011.02.017_bb0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1742-7843.2006.pto_249.x","article-title":"Differential inhibition of cytochrome P450 3A4, 3A5 and 3A7 by five human immunodeficiency virus (HIV) protease inhibitors in vitro","volume":"98","author":"Granfors","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.lfs.2011.02.017_bb0080","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1016\/S0021-9258(19)89213-X","article-title":"Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism","volume":"261","author":"Guengerich","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lfs.2011.02.017_bb0085","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1248\/yakushi1947.103.12_1289","article-title":"Sex difference in the effects of \u03949-tetrahydrocannabinol and cannabidiol on pentobarbital-induced sleeping time and hepatic microsomal drug metabolizing enzyme systems in mice","volume":"103","author":"Hamajima","year":"1983","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.lfs.2011.02.017_bb0090","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0022-3565(25)29124-8","article-title":"Prenatal toxicity, maternal distribution and placental transfer of tetrahydrocannabinol","volume":"180","author":"Harbison","year":"1972","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lfs.2011.02.017_bb0095","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/3-540-26573-2_23","article-title":"Pharmacokinetics and metabolism of the plant cannabinoids, \u03949-tetrahydrocannabinol, cannabidiol and cannabinol","volume":"168","author":"Huestis","year":"2005","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.lfs.2011.02.017_bb0100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/jat\/16.5.276","article-title":"Blood cannabinoids. I. absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana","volume":"16","author":"Huestis","year":"1992","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.lfs.2011.02.017_bb0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ntt.2004.11.002","article-title":"Marijuana impairs growth in mid-gestation fetuses","volume":"27","author":"Hurd","year":"2005","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.lfs.2011.02.017_bb0110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/00498259609046707","article-title":"Inhibition of cyclosporine and tetrahydrocannabinol metabolism by cannabidiol in mouse and human microsomes","volume":"26","author":"Jaeger","year":"1996","journal-title":"Xenobiotica"},{"key":"10.1016\/j.lfs.2011.02.017_bb0115","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0003-9861(85)90383-2","article-title":"Purification and properties of cytochrome P-450 from homogenates of human fetal livers","volume":"241","author":"Kitada","year":"1985","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.lfs.2011.02.017_bb0120","doi-asserted-by":"crossref","first-page":"13534","DOI":"10.1016\/S0021-9258(19)76460-6","article-title":"P-450 HFLa, a form of cytochrome P-450 purified from human fetal livers, is the 16\u03b1-hydroxylase of dehydroepiandrosterone 3-sulfate","volume":"262","author":"Kitada","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lfs.2011.02.017_bb0125","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1124\/dmd.30.10.1108","article-title":"Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA","volume":"30","author":"Koch","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.lfs.2011.02.017_bb0130","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1021\/bi00470a024","article-title":"Fetus-specific expression of a form of cytochrome P-450 in human livers","volume":"29","author":"Komori","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.lfs.2011.02.017_bb0135","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86882","article-title":"Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression","volume":"27","author":"Kuehl","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.lfs.2011.02.017_bb0140","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/0006-2952(73)90028-2","article-title":"Metabolism and distribution of cannabinoids in rats after different methods of administration","volume":"22","author":"Leighty","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.lfs.2011.02.017_bb0145","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/03602530701690374","article-title":"Drugs as CYP3A probes, inducers, and inhibitors","volume":"39","author":"Liu","year":"2007","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.lfs.2011.02.017_bb0150","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lfs.2011.02.017_bb0155","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1124\/dmd.32.10.1083","article-title":"Differences in the inhibition of cytochromes P450 3A4 and 3A5 by metabolite-inhibitor complex-forming drugs","volume":"32","author":"McConn","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.lfs.2011.02.017_bb0160","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1146\/annurev.bi.64.070195.001221","article-title":"The roles of retinoids in vertebrate development","volume":"64","author":"Means","year":"1995","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.lfs.2011.02.017_bb0165","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","article-title":"Cannabidiol: an overview of some pharmacological aspects","volume":"42","author":"Mechoulam","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.lfs.2011.02.017_bb0170","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1073\/pnas.83.14.5311","article-title":"Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver","volume":"83","author":"Molowa","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.lfs.2011.02.017_bb0175","series-title":"The cannabinoids: chemical, pharmacologic, and therapeutic aspects","first-page":"219","article-title":"Single dose kinetics of cannabidiol in man","author":"Ohlsson","year":"1984"},{"key":"10.1016\/j.lfs.2011.02.017_bb0180","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.lfs.2011.02.017_bb0185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1081\/DMR-120001392","article-title":"Summary of information on human CYP enzymes: human P450 metabolism data","volume":"34","author":"Rendic","year":"2002","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.lfs.2011.02.017_bb0190","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1172\/JCI116607","article-title":"Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta","volume":"92","author":"Schuetz","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lfs.2011.02.017_bb0195","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0022-3565(25)22379-5","article-title":"Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians","volume":"270","author":"Shimada","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lfs.2011.02.017_bb0200","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.TP.0000090753.99170.89","article-title":"Impact of cytochrome P450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients","volume":"76","author":"Thervet","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.lfs.2011.02.017_bb0205","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1248\/bpb1978.4.604","article-title":"In vitro and in vivo interactions of \u03948-tetrahydrocannabinol and its metabolites with hepatic microsomal drug metabolizing enzyme systems of mice","volume":"4","author":"Watanabe","year":"1981","journal-title":"J Pharmacobiodyn"},{"key":"10.1016\/j.lfs.2011.02.017_bb0210","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1248\/bpb.18.1138","article-title":"Involvement of CYP2C in the metabolism of cannabinoids by human hepatic microsomes from an old woman","volume":"18","author":"Watanabe","year":"1995","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.lfs.2011.02.017_bb0215","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.lfs.2006.12.032","article-title":"Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes","volume":"80","author":"Watanabe","year":"2007","journal-title":"Life Sci"},{"key":"10.1016\/j.lfs.2011.02.017_bb0220","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1124\/dmd.30.8.883","article-title":"Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7","volume":"30","author":"Williams","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.lfs.2011.02.017_bb0225","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.clpt.2004.02.005","article-title":"CYP3A5 genotype and midazolam clearance in Australian patients receiving chemotherapy","volume":"75","author":"Wong","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.lfs.2011.02.017_bb0230","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0026-895X(25)09114-X","article-title":"Identification of a polymorphically expressed member of the human cytochrome P-450III family","volume":"36","author":"Wrighton","year":"1989","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.lfs.2011.02.017_bb0235","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.bcp.2003.08.004","article-title":"Effects of cytochrome b5 on drug oxidation activities of human cytochrome P450 (CYP) 3As: similarity of CYP3A5 with CYP3A4 but not CYP3A7","volume":"66","author":"Yamaori","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.lfs.2011.02.017_bb0240","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2133\/dmpk.19.120","article-title":"CYP3A5 contributes significantly to CYP3A-mediated drug oxidations in liver microsomes from Japanese subjects","volume":"19","author":"Yamaori","year":"2004","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.lfs.2011.02.017_bb0245","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.bcp.2010.01.028","article-title":"Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes","volume":"79","author":"Yamaori","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.lfs.2011.02.017_bb0250","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM198903233201203","article-title":"Effects of maternal marijuana and cocaine use on fetal growth","volume":"320","author":"Zuckerman","year":"1989","journal-title":"N Engl J Med"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320511000920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320511000920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:09:36Z","timestamp":1758398976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320511000920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":50,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0024320511000920"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2011.02.017","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: Role of phenolic hydroxyl groups in the resorcinol moiety","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2011.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}